Index RUT
P/E 25.60
EPS (ttm) 0.58
Insider Own 16.01%
Shs Outstand 88.34M
Perf Week -0.93%
Market Cap 1.27B
Forward P/E 24.97
EPS next Y 0.59
Insider Trans -0.08%
Shs Float 71.52M
Perf Month -13.50%
Income 57.27M
PEG 3.71
EPS next Q 0.09
Inst Own 90.52%
Short Float 15.95%
Perf Quarter -38.47%
Sales 1.14B
P/S 1.11
EPS this Y -13.23%
Inst Trans -8.71%
Short Ratio 5.03
Perf Half Y -45.63%
Book/sh 4.92
P/B 3.02
EPS next Y 10.59%
ROA 8.26%
Short Interest 11.41M
Perf Year -58.18%
Cash/sh 2.77
P/C 5.37
EPS next 5Y 6.89%
ROE 12.05%
52W Range 13.39 - 42.08
Perf YTD -60.03%
Dividend Est. -
P/FCF 7.89
EPS past 5Y -
ROI 12.69%
52W High -64.69%
Beta 1.35
Dividend TTM -
Quick Ratio 2.62
Sales past 5Y 61.75%
Gross Margin 21.68%
52W Low 10.98%
ATR (14) 0.68
Dividend Ex-Date -
Current Ratio 2.62
EPS Y/Y TTM 10.39%
Oper. Margin 5.75%
RSI (14) 44.89
Volatility 4.91% 4.37%
Employees 566
Debt/Eq 0.04
Sales Y/Y TTM 10.24%
Profit Margin 5.03%
Recom 2.40
Target Price 18.86
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q -29.51%
Payout 0.00%
Rel Volume 0.36
Prev Close 15.41
Sales Surprise -3.45%
EPS Surprise -23.08%
Sales Q/Q 2.04%
Earnings Nov 12 AMC
Avg Volume 2.27M
Price 14.86
SMA20 -0.51%
SMA50 -4.58%
SMA200 -40.60%
Trades
Volume 814,513
Change -3.57%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-02-24 Downgrade
JP Morgan
Overweight → Neutral
$17
Nov-13-24 Downgrade
Truist
Buy → Hold
$26 → $19
Sep-19-24 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Aug-07-24 Downgrade
Leerink Partners
Outperform → Market Perform
$31 → $25
Aug-07-24 Downgrade
Canaccord Genuity
Buy → Hold
$37 → $24
Aug-07-24 Downgrade
BTIG Research
Buy → Neutral
Jul-16-24 Initiated
JMP Securities
Mkt Outperform
$36
May-10-24 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Feb-26-24 Initiated
Leerink Partners
Outperform
$49
Jan-03-24 Initiated
Barclays
Overweight
$48
Sep-27-23 Initiated
Canaccord Genuity
Buy
$46
May-22-23 Initiated
BTIG Research
Buy
$50
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$44
Jan-05-23 Downgrade
SVB Leerink
Outperform → Mkt Perform
$34
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$55
Sep-07-22 Initiated
Truist
Buy
$56
Dec-02-21 Initiated
Jefferies
Buy
$60
Nov-22-21 Downgrade
Citigroup
Buy → Neutral
$60 → $64
Sep-30-21 Initiated
Berenberg
Buy
$81
Aug-12-21 Initiated
Barclays
Overweight
$64
Show Previous Ratings
Dec-11-24 10:38PM
Dec-02-24 01:38PM
Nov-29-24 09:59AM
Nov-18-24 09:08AM
Nov-14-24 09:00AM
06:45AM
Loading…
06:45AM
Nov-13-24 04:40PM
02:19AM
Nov-12-24 05:35PM
04:30PM
(Associated Press Finance)
04:02PM
Nov-11-24 07:10AM
Nov-08-24 09:20AM
Oct-29-24 02:00PM
Oct-21-24 08:12PM
11:17AM
Loading…
Oct-14-24 11:17AM
Oct-10-24 01:58PM
Oct-07-24 11:45AM
Oct-05-24 04:23PM
Oct-02-24 12:42PM
Sep-30-24 02:41PM
Sep-23-24 03:41PM
02:00PM
Sep-19-24 04:17PM
02:46PM
02:15PM
11:37AM
11:30AM
10:53AM
09:12AM
06:43PM
Loading…
Sep-06-24 06:43PM
Sep-03-24 02:26AM
Aug-23-24 08:46AM
Aug-07-24 01:48PM
12:26PM
(Thomson Reuters StreetEvents)
Aug-06-24 08:00PM
05:35PM
04:32PM
(Associated Press Finance)
04:02PM
Jul-30-24 10:01AM
06:19AM
Jul-24-24 08:59AM
Jul-23-24 02:00PM
Jul-18-24 05:00PM
Jun-26-24 01:42PM
Jun-24-24 07:00AM
Jun-20-24 08:59AM
Jun-11-24 11:00AM
Jun-04-24 03:00PM
Jun-02-24 07:58PM
May-22-24 05:00PM
May-17-24 05:27AM
May-14-24 11:00AM
May-10-24 03:24PM
02:01PM
01:20PM
11:26AM
11:07AM
08:53AM
07:30AM
06:16AM
May-09-24 08:57PM
04:38PM
04:32PM
(Associated Press Finance)
04:01PM
May-03-24 02:48AM
Apr-25-24 02:00PM
Apr-17-24 09:23AM
Apr-13-24 12:18PM
Apr-04-24 08:59AM
Apr-03-24 07:01PM
Mar-30-24 01:30AM
Mar-28-24 08:13AM
01:37AM
Mar-26-24 07:49AM
Mar-18-24 12:00PM
Mar-13-24 04:30PM
Mar-11-24 12:00PM
Feb-29-24 05:48PM
07:30AM
Feb-28-24 10:41AM
10:15AM
09:01AM
07:19AM
(Thomson Reuters StreetEvents)
Feb-27-24 05:11PM
(Associated Press Finance)
04:34PM
04:01PM
Feb-13-24 04:30PM
Feb-08-24 03:06AM
Feb-05-24 11:30PM
Jan-24-24 01:36PM
Jan-17-24 09:30AM
Jan-16-24 06:10PM
Jan-12-24 09:23AM
05:03AM
Jan-11-24 09:01AM
Jan-08-24 10:30AM
Jan-06-24 03:12AM
Jan-05-24 03:02AM
Dec-29-23 09:01PM
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SEIDENBERG BETH C Director Dec 09 '24 Proposed Sale 15.82 39,680 627,648 Dec 09 08:27 PM Sturmer Michael E PRESIDENT Jul 16 '24 Sale 30.00 9,030 270,900 362,583 Jul 18 01:19 PM Scott Cheryl Director Jun 28 '24 Sale 28.39 1,462 41,506 10,098 Jul 01 02:14 PM Sturmer Michael E PRESIDENT May 01 '24 Sale 31.95 4,515 144,254 380,038 May 02 07:05 PM Schlanger David J Executive Chairman Apr 01 '24 Option Exercise 3.95 1,000 3,950 87,312 Apr 03 05:27 PM Schlanger David J Executive Chairman Apr 01 '24 Sale 37.52 1,000 37,522 83,631 Apr 03 05:27 PM Sturmer Michael E PRESIDENT Apr 01 '24 Sale 37.60 6,395 240,452 384,553 Apr 03 05:23 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Apr 01 '24 Option Exercise 3.95 20,627 81,477 72,875 Apr 03 05:16 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Apr 01 '24 Sale 37.62 11,165 419,979 50,119 Apr 03 05:16 PM Schlanger David J Executive Chairman Mar 27 '24 Option Exercise 3.95 71,272 281,845 157,584 Mar 29 07:01 PM Schlanger David J Executive Chairman Mar 27 '24 Sale 37.80 71,272 2,694,267 86,312 Mar 29 07:01 PM Schlanger David J Executive Chairman Mar 25 '24 Option Exercise 3.95 2,597 10,270 88,909 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 26 '24 Option Exercise 3.95 305 1,206 86,617 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 25 '24 Sale 37.65 2,597 97,778 86,312 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 26 '24 Sale 37.50 305 11,439 86,312 Mar 27 05:49 PM Schlanger David J Executive Chairman Mar 21 '24 Option Exercise 3.95 5,826 23,039 92,138 Mar 25 06:42 PM Schlanger David J Executive Chairman Mar 21 '24 Sale 37.74 5,826 219,877 86,312 Mar 25 06:42 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Mar 01 '24 Option Exercise 3.95 22,000 86,900 65,647 Mar 05 05:04 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Mar 01 '24 Sale 36.64 12,610 461,977 38,254 Mar 05 05:04 PM Sturmer Michael E PRESIDENT Mar 01 '24 Sale 36.63 11,009 403,260 141,738 Mar 05 04:57 PM Sturmer Michael E PRESIDENT Feb 06 '24 Sale 40.00 2,260 90,400 158,532 Feb 08 06:53 PM Schlanger David J Executive Chairman Feb 05 '24 Option Exercise 3.95 20,000 79,090 106,312 Feb 07 06:38 PM Schlanger David J Executive Chairman Feb 05 '24 Sale 38.50 20,000 769,928 86,312 Feb 07 06:38 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Feb 01 '24 Option Exercise 3.95 22,000 86,900 68,871 Feb 05 07:03 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Feb 01 '24 Sale 37.84 12,651 478,767 43,871 Feb 05 07:03 PM Sturmer Michael E PRESIDENT Feb 01 '24 Sale 37.89 6,395 242,307 160,792 Feb 05 06:57 PM Schlanger David J Executive Chairman Feb 02 '24 Option Exercise 3.95 30,000 118,635 116,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Feb 01 '24 Option Exercise 3.95 30,000 118,635 116,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Feb 02 '24 Sale 38.92 30,000 1,167,490 86,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Feb 01 '24 Sale 38.29 30,000 1,148,635 86,312 Feb 05 06:51 PM Schlanger David J Executive Chairman Jan 08 '24 Option Exercise 3.95 66,002 261,005 152,314 Jan 10 06:31 PM Schlanger David J Executive Chairman Jan 08 '24 Sale 37.88 66,002 2,500,156 86,312 Jan 10 06:31 PM Livingston Mark S. CHIEF FINANCIAL OFFICER Jan 02 '24 Option Exercise 3.95 22,000 86,900 71,871 Jan 05 06:01 AM Livingston Mark S. CHIEF FINANCIAL OFFICER Jan 02 '24 Sale 36.59 12,368 452,540 46,871 Jan 05 06:01 AM Sturmer Michael E PRESIDENT Jan 02 '24 Sale 36.81 6,395 235,400 167,187 Jan 04 06:42 PM Schlanger David J Executive Chairman Jan 02 '24 Option Exercise 3.95 13,998 55,355 102,437 Jan 04 06:30 PM Schlanger David J Executive Chairman Jan 02 '24 Sale 37.58 13,998 526,024 88,439 Jan 04 06:30 PM Schlanger David J Executive Chairman Dec 26 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 27 '23 Option Exercise 3.95 76,031 300,665 164,470 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 26 '23 Sale 37.93 80,000 3,034,760 88,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 27 '23 Sale 37.66 76,031 2,863,525 88,439 Dec 28 08:19 PM Schlanger David J Executive Chairman Dec 22 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 21 '23 Option Exercise 3.95 80,000 316,360 168,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 20 '23 Option Exercise 3.95 2,906 11,492 91,345 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 22 '23 Sale 38.11 80,000 3,048,408 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 21 '23 Sale 37.65 80,000 3,011,952 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 20 '23 Sale 37.50 2,906 108,987 88,439 Dec 22 04:40 PM Schlanger David J Executive Chairman Dec 14 '23 Option Exercise 3.95 1,063 4,204 89,502 Dec 18 07:39 PM Schlanger David J Executive Chairman Dec 14 '23 Sale 37.53 1,063 39,894 88,439 Dec 18 07:39 PM Payson Norman Director Nov 23 '24 Sale 56.29 200 11,258 580,656 Nov 26 04:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite